Sponsored Educational Supplement: Comparison of Tolerability and Adverse Events Following Treatment with Two GnRH Agonists in Patients with Advanced Prostate Cancer
Date
September 1, 2013
Issue
September-October 2013
Volume
Volume 33 Number 5
$15
Standard Price
Publication of this article is supported by a sponsorship provided by Watson Pharma.
· · ·
Speakers
Leanne S. Schimke, MSN, CRNP, FNP-C, CUNP
Nurse Practitioner
Related Products
First Report: U.S. Patient and Clinician Experiences with the inFlow™ Urinary Prosthesis for Permanent Urinary Retention in Women
Kevin M. Connolly discloses that he is an employee of Vesiflo, Inc., the manufacturer of the inFlow™ urinary prosthesis…
Guest Editorial - SUNA Responds to AUA Survey on Outreach to APPs, Nurses, and Associates
The SUNA Board of Directors would like to thank Urologic Nursing Editor Susanne Quallich, PhD, ANP-BC, NP-C, CUNP, FAANP, for her assistance in preparing this paper…
